nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0394	0.0661	CcSEcCtD
Repaglinide—PPARG—forelimb—amyotrophic lateral sclerosis	0.0369	0.183	CbGeAlD
Repaglinide—PPARG—hindlimb—amyotrophic lateral sclerosis	0.0332	0.165	CbGeAlD
Repaglinide—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0318	0.0533	CcSEcCtD
Repaglinide—PPARG—appendage—amyotrophic lateral sclerosis	0.0285	0.141	CbGeAlD
Repaglinide—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0212	0.0356	CcSEcCtD
Repaglinide—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0205	0.0343	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0192	0.0321	CcSEcCtD
Repaglinide—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0264	CcSEcCtD
Repaglinide—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0262	CcSEcCtD
Repaglinide—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0154	0.0259	CcSEcCtD
Repaglinide—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0236	CcSEcCtD
Repaglinide—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.014	0.0235	CcSEcCtD
Repaglinide—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0234	CcSEcCtD
Repaglinide—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0233	CcSEcCtD
Repaglinide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0227	CcSEcCtD
Repaglinide—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0225	CcSEcCtD
Repaglinide—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0216	CcSEcCtD
Repaglinide—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0215	CcSEcCtD
Repaglinide—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0212	CcSEcCtD
Repaglinide—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0203	CcSEcCtD
Repaglinide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.012	0.0201	CcSEcCtD
Repaglinide—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0119	0.02	CcSEcCtD
Repaglinide—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0194	CcSEcCtD
Repaglinide—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0192	CcSEcCtD
Repaglinide—ABCC8—Inwardly rectifying K+ channels—KCNJ10—amyotrophic lateral sclerosis	0.0114	0.0568	CbGpPWpGaD
Repaglinide—ABCC8—brainstem—amyotrophic lateral sclerosis	0.0114	0.0563	CbGeAlD
Repaglinide—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0114	0.019	CcSEcCtD
Repaglinide—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0187	CcSEcCtD
Repaglinide—KCNJ11—Inwardly rectifying K+ channels—KCNJ10—amyotrophic lateral sclerosis	0.0111	0.055	CbGpPWpGaD
Repaglinide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0181	CcSEcCtD
Repaglinide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.01	0.0168	CcSEcCtD
Repaglinide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00988	0.0166	CcSEcCtD
Repaglinide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00965	0.0162	CcSEcCtD
Repaglinide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00952	0.0159	CcSEcCtD
Repaglinide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00952	0.0159	CcSEcCtD
Repaglinide—PPARG—embryo—amyotrophic lateral sclerosis	0.00946	0.0469	CbGeAlD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00945	0.0158	CcSEcCtD
Repaglinide—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00913	0.0153	CcSEcCtD
Repaglinide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00913	0.0153	CcSEcCtD
Repaglinide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.00903	0.0449	CbGpPWpGaD
Repaglinide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00893	0.015	CcSEcCtD
Repaglinide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00886	0.0149	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00831	0.0139	CcSEcCtD
Repaglinide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00819	0.0137	CcSEcCtD
Repaglinide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00803	0.0135	CcSEcCtD
Repaglinide—ABCC8—medulla oblongata—amyotrophic lateral sclerosis	0.00792	0.0392	CbGeAlD
Repaglinide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00788	0.0132	CcSEcCtD
Repaglinide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0078	0.0131	CcSEcCtD
Repaglinide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00746	0.0125	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00729	0.0362	CbGpPWpGaD
Repaglinide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00725	0.0121	CcSEcCtD
Repaglinide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00721	0.0121	CcSEcCtD
Repaglinide—ABCC8—spinal cord—amyotrophic lateral sclerosis	0.00706	0.035	CbGeAlD
Repaglinide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00672	0.0113	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00667	0.0331	CbGpPWpGaD
Repaglinide—KCNJ11—nervous system—amyotrophic lateral sclerosis	0.00646	0.032	CbGeAlD
Repaglinide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00646	0.0108	CcSEcCtD
Repaglinide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00624	0.0105	CcSEcCtD
Repaglinide—KCNJ11—central nervous system—amyotrophic lateral sclerosis	0.00622	0.0308	CbGeAlD
Repaglinide—KCNJ11—cerebellum—amyotrophic lateral sclerosis	0.00608	0.0301	CbGeAlD
Repaglinide—ABCC8—nervous system—amyotrophic lateral sclerosis	0.00595	0.0295	CbGeAlD
Repaglinide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0058	0.00972	CcSEcCtD
Repaglinide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00575	0.00964	CcSEcCtD
Repaglinide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00575	0.00963	CcSEcCtD
Repaglinide—ABCC8—central nervous system—amyotrophic lateral sclerosis	0.00573	0.0284	CbGeAlD
Repaglinide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00572	0.00958	CcSEcCtD
Repaglinide—ABCC8—cerebellum—amyotrophic lateral sclerosis	0.0056	0.0277	CbGeAlD
Repaglinide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00908	CcSEcCtD
Repaglinide—PPARG—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00527	0.0262	CbGpPWpGaD
Repaglinide—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00496	0.0247	CbGpPWpGaD
Repaglinide—KCNJ11—brain—amyotrophic lateral sclerosis	0.00494	0.0245	CbGeAlD
Repaglinide—ABCC8—brain—amyotrophic lateral sclerosis	0.00455	0.0225	CbGeAlD
Repaglinide—PPARG—nervous system—amyotrophic lateral sclerosis	0.00454	0.0225	CbGeAlD
Repaglinide—ABCC8—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.00451	0.0224	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00442	0.022	CbGpPWpGaD
Repaglinide—KCNJ11—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.00437	0.0217	CbGpPWpGaD
Repaglinide—PPARG—central nervous system—amyotrophic lateral sclerosis	0.00437	0.0217	CbGeAlD
Repaglinide—PPARG—brain—amyotrophic lateral sclerosis	0.00347	0.0172	CbGeAlD
Repaglinide—ALB—brain—amyotrophic lateral sclerosis	0.00326	0.0161	CbGeAlD
Repaglinide—PPARG—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.00249	0.0124	CbGpPWpGaD
Repaglinide—CYP2C8—brain—amyotrophic lateral sclerosis	0.00229	0.0113	CbGeAlD
Repaglinide—PPARG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00229	0.0114	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.00209	0.0104	CbGpPWpGaD
Repaglinide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00203	0.01	CbGeAlD
Repaglinide—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.00203	0.0101	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00197	0.00979	CbGpPWpGaD
Repaglinide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00195	0.00967	CbGeAlD
Repaglinide—KCNJ11—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00191	0.00949	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00182	0.00903	CbGpPWpGaD
Repaglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00177	0.0088	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00176	0.00876	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00176	0.00872	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00173	0.00861	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0017	0.00846	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.00165	0.00822	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00161	0.00798	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.00158	0.00783	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00156	0.00774	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00149	0.00742	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00149	0.00742	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.00149	0.0074	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00148	0.00733	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00146	0.00728	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00146	0.00724	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00145	0.00719	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00145	0.00719	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.00142	0.00705	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00133	0.00662	CbGpPWpGaD
Repaglinide—ABCC8—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00133	0.00661	CbGpPWpGaD
Repaglinide—KCNJ11—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00129	0.00641	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00124	0.00615	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.00118	0.00586	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00117	0.00583	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00116	0.00579	CbGpPWpGaD
Repaglinide—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.00116	0.00579	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00115	0.0057	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.0011	0.00547	CbGpPWpGaD
Repaglinide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.00109	0.00544	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00105	0.00521	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00105	0.00521	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.00103	0.00513	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000975	0.00485	CbGpPWpGaD
Repaglinide—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000946	0.0047	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000944	0.00469	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000936	0.00465	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000917	0.00456	CbGpPWpGaD
Repaglinide—PPARG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00091	0.00452	CbGpPWpGaD
Repaglinide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000907	0.00451	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000905	0.0045	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000905	0.0045	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000891	0.00443	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000878	0.00436	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000878	0.00436	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000856	0.00425	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.00084	0.00417	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000834	0.00415	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000828	0.00411	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000827	0.00411	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000803	0.00399	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000802	0.00399	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000802	0.00399	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000798	0.00397	CbGpPWpGaD
Repaglinide—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000794	0.00395	CbGpPWpGaD
Repaglinide—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000774	0.00384	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000771	0.00383	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00077	0.00382	CbGpPWpGaD
Repaglinide—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000762	0.00378	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000746	0.00371	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000734	0.00365	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000724	0.0036	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.00072	0.00358	CbGpPWpGaD
Repaglinide—ABCC8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000715	0.00355	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000702	0.00349	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000686	0.00341	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000667	0.00331	CbGpPWpGaD
Repaglinide—PPARG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000662	0.00329	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000661	0.00328	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000659	0.00327	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000655	0.00326	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000654	0.00325	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000649	0.00322	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000649	0.00322	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—DAO—amyotrophic lateral sclerosis	0.000635	0.00315	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000628	0.00312	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000605	0.00301	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000603	0.003	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000599	0.00298	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000599	0.00298	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000593	0.00295	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000578	0.00287	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00056	0.00278	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000557	0.00277	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000552	0.00274	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000546	0.00271	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000538	0.00267	CbGpPWpGaD
Repaglinide—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000533	0.00265	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000533	0.00265	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000527	0.00262	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000524	0.0026	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000521	0.00259	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000519	0.00258	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000511	0.00254	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000511	0.00254	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000509	0.00253	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000496	0.00246	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000481	0.00239	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000476	0.00237	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000472	0.00235	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—DAO—amyotrophic lateral sclerosis	0.000469	0.00233	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000467	0.00232	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000459	0.00228	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000458	0.00227	CbGpPWpGaD
Repaglinide—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000454	0.00226	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000453	0.00225	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000453	0.00225	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GSR—amyotrophic lateral sclerosis	0.000444	0.00221	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000439	0.00218	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000438	0.00218	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000434	0.00216	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000418	0.00208	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000408	0.00203	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000404	0.00201	CbGpPWpGaD
Repaglinide—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000383	0.0019	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000378	0.00188	CbGpPWpGaD
Repaglinide—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000378	0.00188	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000376	0.00187	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000369	0.00184	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000364	0.00181	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000361	0.00179	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000359	0.00178	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000355	0.00177	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000352	0.00175	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00034	0.00169	CbGpPWpGaD
Repaglinide—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000337	0.00168	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSR—amyotrophic lateral sclerosis	0.000328	0.00163	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000319	0.00159	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000304	0.00151	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000299	0.00148	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000294	0.00146	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000294	0.00146	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000292	0.00145	CbGpPWpGaD
Repaglinide—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000292	0.00145	CbGpPWpGaD
Repaglinide—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000287	0.00142	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000286	0.00142	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00028	0.00139	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000274	0.00136	CbGpPWpGaD
Repaglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000273	0.00136	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000272	0.00135	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000269	0.00134	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000268	0.00133	CbGpPWpGaD
Repaglinide—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000267	0.00133	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000259	0.00129	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000259	0.00129	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000258	0.00128	CbGpPWpGaD
Repaglinide—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000253	0.00126	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00025	0.00124	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000248	0.00123	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000246	0.00122	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000235	0.00117	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000235	0.00117	CbGpPWpGaD
Repaglinide—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000233	0.00116	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000231	0.00115	CbGpPWpGaD
Repaglinide—PPARG—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.00023	0.00115	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000212	0.00105	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000212	0.00105	CbGpPWpGaD
Repaglinide—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000211	0.00105	CbGpPWpGaD
Repaglinide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000206	0.00102	CbGpPWpGaD
Repaglinide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000203	0.00101	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000202	0.001	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000196	0.000973	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000195	0.000968	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000194	0.000962	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000186	0.000922	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00018	0.000894	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000168	0.000837	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000165	0.000822	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000165	0.000818	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000161	0.000799	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00016	0.000795	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000158	0.000783	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000158	0.000783	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—APOE—amyotrophic lateral sclerosis	0.000153	0.000759	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000149	0.000738	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000148	0.000737	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—APOE—amyotrophic lateral sclerosis	0.000148	0.000736	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000148	0.000734	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	0.000148	0.000733	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000145	0.000719	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000144	0.000716	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000135	0.000672	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000134	0.000668	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000134	0.000666	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000133	0.000661	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000133	0.000659	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000127	0.000632	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000126	0.000626	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000122	0.000606	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000121	0.000602	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000114	0.000566	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000114	0.000566	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000111	0.000553	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000111	0.000549	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APOE—amyotrophic lateral sclerosis	0.000109	0.000544	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000105	0.000521	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000105	0.00052	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000101	0.000504	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.0001	0.000499	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	8.63e-05	0.000429	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	8.62e-05	0.000428	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.97e-05	0.000396	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.62e-05	0.000379	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.58e-05	0.000376	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.5e-05	0.000373	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	6.56e-05	0.000326	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.55e-05	0.000325	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	6.54e-05	0.000325	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.51e-05	0.000324	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.02e-05	0.000299	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.99e-05	0.000297	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.91e-05	0.000293	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	4.95e-05	0.000246	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	4.95e-05	0.000246	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	4.92e-05	0.000245	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.52e-05	0.000175	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.39e-05	0.000169	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.37e-05	0.000168	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.23e-05	0.000161	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.66e-05	0.000132	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.82e-05	9.05e-05	CbGpPWpGaD
